Linda Härndahl

Linda Härndahl has a diverse work experience spanning multiple companies and roles. Linda is currently an Associate Director of Project Management at KalVista Pharmaceuticals, Inc. since May 2023, where they were previously a Regulatory Project Manager from September 2022 to May 2023. Prior to that, they worked at Portsmouth Hospitals University NHS Trust from 2013 to 2022, holding positions such as Project Manager for the Portsmouth Research Vaccine Hub, RM&G/Research Manager, and Associate Research Manager. Linda also worked at the NIHR Clinical Research Network as a Clinical Trial Research Facilitator from June 2011 to February 2013. Linda began their career at AstraZeneca in 2005, where they held roles as a Senior Research Scientist and Early Drug Discovery Project Lead and Strategy. Linda also worked as a Postdoctoral Fellow at CVGI AstraZeneca, Alderley Park, UK. Linda completed their postdoctoral fellowship at Newcastle University from February 2004 to September 2005.

Linda Härndahl has a strong educational background in the field of biology. Linda obtained their PhD in Medical Faculty with a specialization in Cell and Molecular Biology from Lund University, where they studied at the Biomedical Centre from 1999 to 2003. Prior to their PhD, Linda also completed their MSc in Cell/Molecular Biology from Lund University, graduating in 1999. In addition to their academic qualifications, Linda has obtained the PRINCE2® Foundation Certification Training from SPOCE PROJECT MANAGEMENT LIMITED in August 2014.